FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108402791> ?p ?o ?g. }

• W3108402791 endingPage "e10295" @default.
• W3108402791 startingPage "e10295" @default.
• W3108402791 abstract "The macrophage lineage is characterized by plasticity due to the acquisition of distinct functional phenotypes, and two major subsets are evaluated; classical M1 activation (strong microbicidal activity) and alternative M2 activation (immunoregulatory functions). The M1 subset expresses inducible nitric oxide synthase (iNOS), which is a primary marker to identify these cells, whereas M2 macrophages are characterized by expression of Arginase-1, found in inflammatory zone 1 (Fizz1), chitinase-like molecule (Ym-1), and CD206. The micro-environmental stimuli and signals in tissues are critical in the macrophage polarization. Toll-like receptors (TLR) ligands, such as lipopolysaccharide (LPS), palmitoyl-3-cysteine-serine-lysine-4 (Pam3CSK4), and ArtinM (mannose-binding lectin) are inductors of M1 subset. The impact of TLR2 and TLR4 signals to fight against Cryptococcus gattii infection is unknown, which is a fungal pathogen that preferentially infects the lung of immunocompetent individuals. The macrophages initiate an immune response to combat the C. gattii, then we evaluated in RAW 264.7 cell the effect of TLR2 and TLR4 agonists on the macrophage polarization dynamic and the impact on the growth of C. gattii.We demonstrated that P3C4, LPS, and ArtinM induced an increase in the levels of iNOS transcripts in RAW 264.7 cells, whereas the relative expression of arginase-1, Ym-1, and Fizz1 was significantly increased in the presence of IL-4 alone. The effects of TLR2 and TLR4 agonists on repolarization from the M2 to M1 subset was evaluated, and the first stimulus was composed of IL-4 and, after 24 h of incubation, the cells were submitted to a second stimulus of P3C4, LPS, ArtinM, or Medium. These TLR agonists induced the production of TNF-α in polarized RAW 264.7 cells to the M2 subset, moreover the measurement of M1/M2 markers using qRT-PCR demonstrated that a second stimulus with LPS for 24 h induced a significant augmentation of levels of iNOS mRNA. This impact of TLR2 and TLR4 agonists in the activation of the RAW 264.7 macrophage was assayed in the presence of C. gattii, the macrophages stimulated with TLR2 and TLR4 agonists for 24 h and co-cultured with C. gattii, as a second stimulus, reached high levels of TNF-α even after incubation with different concentrations of C. gattii. The activation of RAW 264.7 cells induced by TLR2 and TLR4 agonists favored the phagocytosis of C. gattii and inhibited the growth of yeast in the early period of infection. However, RAW 264.7 cells incubated with C. gattii in the presence of TLR2 and TLR4 agonists did not result a significant difference in the colony forming unit (CFU) assay in the early period of C. gattii infection, compared to negative control.Polarized RAW 264.7 cells to the M1 subset with TLR2 and TLR4 agonists did not inhibit the growth of C. gattii, whereas robust immunity was identified that could dysregulate host tolerance to this pathogen." @default.
• W3108402791 created "2020-12-07" @default.
• W3108402791 creator A5018668551 @default.
• W3108402791 creator A5033884812 @default.
• W3108402791 creator A5065823148 @default.
• W3108402791 creator A5066499417 @default.
• W3108402791 creator A5089202111 @default.
• W3108402791 date "2020-11-25" @default.
• W3108402791 modified "2023-10-15" @default.
• W3108402791 title "Pro-inflammatory response ensured by LPS and Pam3CSK4 in RAW 264.7 cells did not improve a fungistatic effect on <i>Cryptococcus gattii</i> infection" @default.
• W3108402791 cites W1985859986 @default.
• W3108402791 cites W1988604605 @default.
• W3108402791 cites W2019221616 @default.
• W3108402791 cites W2065210647 @default.
• W3108402791 cites W2070855360 @default.
• W3108402791 cites W2080693670 @default.
• W3108402791 cites W2081245391 @default.
• W3108402791 cites W2093705034 @default.
• W3108402791 cites W2102642516 @default.
• W3108402791 cites W2104292587 @default.
• W3108402791 cites W2104901632 @default.
• W3108402791 cites W2109483577 @default.
• W3108402791 cites W2112675507 @default.
• W3108402791 cites W2114400198 @default.
• W3108402791 cites W2121438383 @default.
• W3108402791 cites W2123303185 @default.
• W3108402791 cites W2130594874 @default.
• W3108402791 cites W2131227412 @default.
• W3108402791 cites W2131741092 @default.
• W3108402791 cites W2139426562 @default.
• W3108402791 cites W2150395262 @default.
• W3108402791 cites W2150822410 @default.
• W3108402791 cites W2161052986 @default.
• W3108402791 cites W2168373615 @default.
• W3108402791 cites W2549345337 @default.
• W3108402791 cites W2563076883 @default.
• W3108402791 cites W2623215719 @default.
• W3108402791 cites W2626830171 @default.
• W3108402791 cites W2737694430 @default.
• W3108402791 cites W2767972305 @default.
• W3108402791 cites W2771561797 @default.
• W3108402791 cites W2782685575 @default.
• W3108402791 cites W2786275743 @default.
• W3108402791 cites W2801573336 @default.
• W3108402791 cites W2898151380 @default.
• W3108402791 cites W2967030209 @default.
• W3108402791 cites W2969693470 @default.
• W3108402791 cites W2969871827 @default.
• W3108402791 cites W2983619046 @default.
• W3108402791 cites W3014987953 @default.
• W3108402791 cites W3017344700 @default.
• W3108402791 cites W3034567703 @default.
• W3108402791 doi "https://doi.org/10.7717/peerj.10295" @default.
• W3108402791 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7698691" @default.
• W3108402791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33304649" @default.
• W3108402791 hasPublicationYear "2020" @default.
• W3108402791 type Work @default.
• W3108402791 sameAs 3108402791 @default.
• W3108402791 citedByCount "7" @default.
• W3108402791 countsByYear W31084027912021 @default.
• W3108402791 countsByYear W31084027912022 @default.
• W3108402791 countsByYear W31084027912023 @default.
• W3108402791 crossrefType "journal-article" @default.
• W3108402791 hasAuthorship W3108402791A5018668551 @default.
• W3108402791 hasAuthorship W3108402791A5033884812 @default.
• W3108402791 hasAuthorship W3108402791A5065823148 @default.
• W3108402791 hasAuthorship W3108402791A5066499417 @default.
• W3108402791 hasAuthorship W3108402791A5089202111 @default.
• W3108402791 hasBestOaLocation W31084027911 @default.
• W3108402791 hasConcept C111289621 @default.
• W3108402791 hasConcept C134018914 @default.
• W3108402791 hasConcept C136449434 @default.
• W3108402791 hasConcept C164007495 @default.
• W3108402791 hasConcept C202751555 @default.
• W3108402791 hasConcept C203014093 @default.
• W3108402791 hasConcept C2776070231 @default.
• W3108402791 hasConcept C2776205754 @default.
• W3108402791 hasConcept C2776682551 @default.
• W3108402791 hasConcept C2777468819 @default.
• W3108402791 hasConcept C2777622882 @default.
• W3108402791 hasConcept C2778952914 @default.
• W3108402791 hasConcept C2779244956 @default.
• W3108402791 hasConcept C2779286289 @default.
• W3108402791 hasConcept C2781236682 @default.
• W3108402791 hasConcept C515207424 @default.
• W3108402791 hasConcept C519581460 @default.
• W3108402791 hasConcept C55493867 @default.
• W3108402791 hasConcept C86803240 @default.
• W3108402791 hasConcept C8891405 @default.
• W3108402791 hasConcept C89423630 @default.
• W3108402791 hasConcept C95444343 @default.
• W3108402791 hasConceptScore W3108402791C111289621 @default.
• W3108402791 hasConceptScore W3108402791C134018914 @default.
• W3108402791 hasConceptScore W3108402791C136449434 @default.
• W3108402791 hasConceptScore W3108402791C164007495 @default.
• W3108402791 hasConceptScore W3108402791C202751555 @default.
• W3108402791 hasConceptScore W3108402791C203014093 @default.
• W3108402791 hasConceptScore W3108402791C2776070231 @default.

• next